Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

60 Degrees Pharmaceuticals Inc (SXTP)

60 Degrees Pharmaceuticals Inc (SXTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,072
  • Shares Outstanding, K 1,058
  • Annual Sales, $ 680 K
  • Annual Income, $ -7,950 K
  • EBIT $ -8 M
  • EBITDA $ -4 M
  • 60-Month Beta 2.94
  • Price/Sales 1.99
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -2.28
  • Number of Estimates 2
  • High Estimate -2.00
  • Low Estimate -2.56
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.36 +205.88%
on 01/14/26
8.62 -51.74%
on 01/22/26
+2.10 (+101.90%)
since 01/06/26
3-Month
1.36 +205.88%
on 01/14/26
8.62 -51.74%
on 01/22/26
-1.04 (-20.00%)
since 11/06/25
52-Week
1.36 +205.88%
on 01/14/26
17.68 -76.47%
on 04/22/25
-6.42 (-60.68%)
since 02/06/25

Most Recent Stories

More News
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership

GoodRx to offer prescription savings of up to 30% for ARAKODA ® ( tafenoquine ) Collaboration designed to lower patient out-of-pocket costs and expand the reach of Company’s marketing strategy Partnership...

GDRX : 2.44 (+6.55%)
SXTP : 4.16 (+8.05%)
SXTPW : 0.0683 (unch)
60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use

WASHINGTON, Jan. 28, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc.  (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing...

SXTP : 4.16 (+8.05%)
SXTPW : 0.0683 (unch)
60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA® for Malaria Prevention

Partnership adds a travel-focused consumer telehealth platform to the ARAKODA ® marketing strategy, offering a new convenience to people planning travel to malaria-endemic regions of the world ARAKODA...

SXTP : 4.16 (+8.05%)
SXTPW : 0.0683 (unch)
60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio

WASHINGTON, Jan. 15, 2026 (GLOBE NEWSWIRE) -- 60 Degree Pharmaceuticals, Inc. NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines...

SXTP : 4.16 (+8.05%)
SXTPW : 0.0683 (unch)
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State

Further validates continuation of the B-FREE Study to evaluate the efficacy and safety of ARAKODA ® ( tafenoquine ) for treatment of chronic babesiosis Data support theory among specialists that Babesia...

SXTP : 4.16 (+8.05%)
SXTPW : 0.0683 (unch)
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / December 26, 2025 / RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip...

PCSA : 2.38 (+9.68%)
SXTP : 4.16 (+8.05%)
60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026

6-month commercial pilot demonstrated increasing demand among prescribers Expansion plan includes doubling the number of sales reps, a new GoodRx partnership, and enhanced digital marketing campaign ...

SXTP : 4.16 (+8.05%)
SXTPW : 0.0683 (unch)
60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine

90-day trial will measure change in general fatigue in patients with chronic babesiosis following  tafenoquine treatment Study will run approximately 12 months and enroll up to 100 patients Internal...

SXTP : 4.16 (+8.05%)
SXTPW : 0.0683 (unch)
60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results

Q3 2025 net product revenue increased 223% year-over-year to $438 thousand Gross profit/(loss) decreased from $24 thousand to $(100) thousand WASHINGTON, Nov. 13, 2025 (GLOBE NEWSWIRE) -- 60...

SXTP : 4.16 (+8.05%)
SXTPW : 0.0683 (unch)
60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FLORIDA / ACCESS Newswire / October 31, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) and NDT Pharmaceuticals Inc. (OTC:NDTP) on the RedChip...

SXTP : 4.16 (+8.05%)
NDTP : 1.0200 (+7.37%)

Business Summary

60 Degrees Pharmaceuticals Inc. specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. 60 Degrees Pharmaceuticals Inc. is based in WASHINGTON.

See More

Key Turning Points

3rd Resistance Point 4.96
2nd Resistance Point 4.56
1st Resistance Point 4.36
Last Price 4.16
1st Support Level 3.76
2nd Support Level 3.36
3rd Support Level 3.16

See More

52-Week High 17.68
Fibonacci 61.8% 11.45
Fibonacci 50% 9.52
Fibonacci 38.2% 7.59
Last Price 4.16
52-Week Low 1.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar